You searched for "vascular"
Bromfenac versus betamethasone in diabetic macular oedema
31 October 2023
| Kurt Spiteri Cornish
|
EYE - Vitreo-Retinal
|
Diabetic macular edema, betamethasone, bromfenac, central subfield thickness, intraocular pressure
This is a randomised, prospective, single-centre trial in patients diagnosed with diabetic macular oedema (DMO) with central subfield thickness (CST) of 250-500µm, who refused anti-VEGF treatment. Nineteen eyes of 19 patients were randomised to bromfenac (BF) or betamethasone (BM) drops,...
The compendium to clinical evidence in DMO treatment
3 April 2024
| Zhihang Cheng
|
EYE - Vitreo-Retinal
This review article summarises the current evidence base in the treatment options for diabetic macular oedema (DMO). The authors have included many real-world data studies that provided valuable insights into the optimal management of DMO. The authors argue that these...
Comprehensive review of inherited retinal diseases
3 June 2024
| Zhihang Cheng
|
EYE - Vitreo-Retinal
The authors offer an up-to-date review of inherited retinal diseases (IRDs). In each section the authors discuss the molecular basis of disease, genotype and clinical manifestation. They also discuss the investigation findings and current evidence in the treatment of the...
OCT measurements in neurodevelopmental conditions
The authors aimed to investigate what changes occur in the retinal nerve fibre layer (RNFL), ganglion cell layer (GCL) and macula when specific learning disorder (SLD) comorbidity is added to attention deficit hyperactivity disorder (ADHD). They compared measures in three...
Long-term treatment for diabetic macular oedema
2 April 2025
| Kurt Spiteri Cornish
|
EYE - Vitreo-Retinal
The authors set out to characterise anti-VEGF treatment patterns and long-term outcomes in patients with diabetic macular oedema. A retrospective analysis of over 190 thousand patients on the Intelligent Research in Sight registry was performed. Of these, 1236 eyes have...
Moorfeilds: Medical retina pathways consent course
3 October 2025
This brand new, unique MR Pathways consent course is specially designed for nurses, optometrists, doctors and others healthcare professional groups working in medical retina subspeciality in ophthalmology. The MR Pathway consent course enables the multi professional groups to embed the...
Is it NAION… Now what?
3 April 2024
| Urvi Patel
|
EYE - Neuro-ophthalmology
Case presentation We present the case and discussion of a 46-year-old Caucasian male who complained of immediate reduced vision following complicated neck dissection including a total laryngopharyngectomy, free flap reconstruction for a T4N3 squamous cell carcinoma (SCC) of the left...
100 years of insulin
3 October 2022
| Aaron Carlisle, Kieran Walshe, Lloyd Paul Aiello (Prof), Tunde Peto, Katie Curran
|
EYE - General
*Joint first authors The centenary of the discovery of insulin is a time to celebrate one of the most significant scientific discoveries of the 20th century. Background Before 1923, Type 1 diabetes mellitus [T1DM] resulted in death from severe ketoacidosis...
Treatment efficacy of stage 4 ROP
This study aimed to determine the efficacy of combined vitrectomy and anti-VEGF injection for advanced stage 4 ROP with extensive neovascular proliferation (NF). The study included nine infants; six bilateral and three unilateral. Seven were female and the mean gestational...The results of the last survey Jun24
When I was in my training and even in my early years as a consultant, I did not fully understand the difference between different lenses. When asked my preference of hydrophilic versus hydrophobic intraocular lenses (IOLs) I really did not...An update on inherited retinal disorders (part 2): Approaches to therapy for IRDs
1 December 2016
| Stacey Strong, Michel Michaelides (Prof)
|
EYE - Vitreo-Retinal
Part 1 of this topic can be found here There are currently no proven cures for inherited retinal disease (IRD). However, multiple avenues of research are being investigated to better understand disease mechanisms and trial potential therapies that may slow...
White dot syndromes
1 September 2015
| Gwyn Samuel Williams
|
EYE - Vitreo-Retinal
It is fair to say that trainees and consultants who are not medical retina specialists are a bit scared of the so called retinal ‘white dot syndromes’. It is easy to understand why this is the case, as almost every...
